-
Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized TrialsElgendy IY, Mahmoud AN, Kumbhani DJ et al. -
Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH TrialGJ Vlachojannis , JM Wilschut , RF Vogel et al.
-
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus StatementPB Shah, FGP Welt, E Mahmud et al.
-
High-Sensitivity Troponin and The Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary SyndromeA Bularga, KK Lee, the High-STEACS Investigators et al.
-
4-Step Protocol for Disparities in STEMI Care and Outcomes in WomenCP Huded, M Johnson, UN Khot et al.
-
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialValgimigli M, Frigoli E, MATRIX Investigators.
-
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialWang TY, Kaltenbach LA, Cannon CP et al.
-
Multivessel PCI Guided by FFR or Angiography for Myocardial InfarctionE Puymirat, G Cayla, for the FLOWER-MI Study Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
